Bupropion Reduces Nicotine Addiction

Worldwide, tobacco use is a major behavioral risk factor for cancer. A comparative study conducted in 2017 showed that 7.10 million deaths were associated with smoking. Tobacco consumption not only increases the risk of developing various forms of cancer, but also reduces life expectancy after suffering a cancer, and increases the risk of relapse. In patients with lung cancer who underwent lung resection, smoking increased the risk of nosocomial mortality by three times and significantly increased the incidence of pulmonary complications. In addition to the localization and stage of cancer, abstinence from tobacco consumption has been noted as the strongest predictor of survival in cancer patients. In the United States, National Recommendations for Comprehensive Cancer Treatment (NCCN) included recommendations for the treatment of nicotine addiction, including 12 weeks of behavioral therapy (including telephone counseling) in combination with smoking cessation drugs for all patients receiving treatment in oncological clinics. Treatment of nicotine addiction has proven cost-effective: in particular, it has been shown for a smoking cessation program prior to surgical resection of the lung. Principles 5 A are recommended by the World Health Organization (WHO) to assist in the smoking cessation. There are national guidelines in other countries. In the Russian Federation, clinical guidelines “Tobacco addiction syndrome, tobacco withdrawal syndrome in adults” were adopted. Given the significant impact of smoking on the prognosis of cancer, the treatment of nicotine addiction should be an integral part of the treatment of malignant tumors. The most effective treatment is the combination of pharmacotherapy and cognitive-behavioral therapy. Teaching behavioral methods to overcome the withdrawal syndrome can be conducted by calling the to Quitline, organized by the Ministry of Health of the Russian Federation.

Download Full-text

Linking nicotine addiction and T2DM

Nature Reviews Endocrinology ◽

10.1038/s41574-019-0285-4 ◽

2019 ◽

Vol 16 (1) ◽

pp. 6-6 ◽

Cited By ~ 1

Author(s):

Alan Morris

Keyword(s):

Nicotine Addiction

Download Full-text

Evidence of Nicotine Dependence in Adolescents Who Use Juul and Similar Pod Devices

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph16122135 ◽

2019 ◽

Vol 16 (12) ◽

pp. 2135 ◽

Cited By ~ 12

Author(s):

Rachel Boykan ◽

Maciej L. Goniewicz ◽

Catherine R. Messina

Keyword(s):

Nicotine Dependence ◽

Early Onset ◽

Nicotine Addiction ◽

Urinary Cotinine ◽

Nicotine Content ◽

The Past ◽

Survey Responses

Background: The use of high-nicotine content e-cigarettes (so-called pods, such as Juul) among adolescents raises concerns about early onset of nicotine addiction. Methods: In this analysis of adolescents surveyed from April 2017–April 2018, we compare survey responses and urinary cotinine of pod vs. non-pod using past-week e-cigarette users aged 12–21. Results: More pod users categorized themselves as daily users compared to non-pod users (63.0% vs. 11.0%; p = 0.001); more pod than non-pod users had used e-cigarettes within the past day (76.2% vs. 29.6%; p = 0.001). More pod users responded affirmatively to nicotine dependence questions (21.4% vs. 7.1%; p = 0.04). Urinary cotinine levels were compared among those responding positively and negatively to dependence questions: those with positive responses had significantly higher urinary cotinine levels than those responding negatively. Conclusions: Adolescents who used pod products showed more signs of nicotine dependence than non-pod users. Pediatricians should be vigilant in identifying dependence symptoms in their patients who use e-cigarettes, particularly in those using pod devices.

Download Full-text